Sabra Health Care REIT Announces Board and Compensation Changes
Ticker: SBRA · Form: 8-K · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-changes
TL;DR
Sabra REIT shakes up board, adjusts exec pay.
AI Summary
Sabra Health Care REIT, Inc. announced on November 7, 2024, changes in its board of directors and executive compensation. Specifically, the company reported the departure of director Michael A. Weil and the appointment of new directors, along with updates to its compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing details routine corporate governance changes and compensation adjustments, which are common and typically do not represent significant new risks.
Key Numbers
- 001-34950 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-2560479 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Sabra Health Care REIT, Inc. (company) — Registrant
- Michael A. Weil (person) — Departing Director
- November 7, 2024 (date) — Date of earliest event reported
- Maryland (location) — State of Incorporation
- Irvine, CA (location) — Principal Executive Offices
FAQ
Who has departed from Sabra Health Care REIT's board of directors?
Michael A. Weil has departed from the board of directors as of November 7, 2024.
What are the main items reported in this 8-K filing?
This filing reports the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 7, 2024.
What is Sabra Health Care REIT's state of incorporation?
Sabra Health Care REIT, Inc. is incorporated in Maryland.
Where are Sabra Health Care REIT's principal executive offices located?
Sabra Health Care REIT, Inc.'s principal executive offices are located at 18500 Von Karman Street, Suite 550, Irvine, CA 92612.
From the Filing
0001492298-24-000033.txt : 20241112 0001492298-24-000033.hdr.sgml : 20241112 20241112092025 ACCESSION NUMBER: 0001492298-24-000033 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241107 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sabra Health Care REIT, Inc. CENTRAL INDEX KEY: 0001492298 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 272560479 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34950 FILM NUMBER: 241444097 BUSINESS ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 888-393-8248 MAIL ADDRESS: STREET 1: 18500 VON KARMAN STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 8-K 1 sbra-20241107.htm 8-K sbra-20241107 false 0001492298 0001492298 2024-11-07 2024-11-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  November 7, 2024 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter)   Maryland   001-34950   27-2560479 (State of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   1781 Flight Way Tustin CA 92782 (Address of principal executive offices) (Zip Code) Registrant's telephone number including area code: ( 888 )  393-8248   (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, $0.01 par value SBRA The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b)    On November 7, 2024, Clifton J. Porter II notified the Board of Directors of Sabra Health Care REIT, Inc. (the “Company”) of his decision not to stand for reelection to the Company’s Board of Directors at the Company’s 2025 annual meeting of shareholders. Mr. Porter’s decision not to stand for reelection does not relate to any disagreement on matters relating to the Company’s operations, policies or practices or any other matter. On behalf of the Board of Directors, Richard K. Matros, the Company’s Chair and Chief Executive Officer, thanked Mr. Porter